Benjamin Levy

Associate Professor

19982019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Benjamin Levy is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 16 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • 32 Article
  • 10 Review article
  • 2 Comment/debate
  • 1 Conference contribution

Afatinib With Pembrolizumab for Treatment of Patients With Locally Advanced/Metastatic Squamous Cell Carcinoma of the Lung: The LUX-Lung IO/KEYNOTE 497 Study Protocol

Levy, B., Paz-Ares, L., Bennouna, J., Felip, E., Abreu, D. R., Isla, D., Barlesi, F., Molinier, O., Madelaine, J., Audigier-Valette, C., Kim, S. W., Kim, H. R., Ozguroglu, M., Erman, M., Badin, F. B., Mekhail, T. M., Scheff, R., Chisamore, M. J., Sadrolhefazi, B. & Riess, J. W., Jan 1 2019, In : Clinical Lung Cancer.

Research output: Contribution to journalArticle

Open Access
  • Dynamics of tumor and immune responses during immune checkpoint blockade in non–small cell lung cancer

    Anagnostou, V., Forde, P. M., White, J. R., Niknafs, N., Hruban, C., Naidoo, J., Marrone, K., Ashok Sivakumar, I. K., Bruhm, D. C., Rosner, S., Phallen, J., Leal, A., Adleff, V., Smith, K. N., Cottrell, T. R., Rhymee, L., Palsgrove, D. N., Hann, C. L., Levy, B., Feliciano, J. & 16 others, Georgiades, C., Verde, F., Illei, P., Li, Q. K., Gabrielson, E., Brock, M. V., Isbell, J. M., Sauter, J. L., Taube, J., Scharpf, R. B., Karchin, R., Pardoll, D. M., Chaft, J. E., Hellmann, M. D., Brahmer, J. R. & Velculescu, V. E., Jan 1 2019, In : Cancer Research. 79, 6, p. 1214-1225 12 p.

    Research output: Contribution to journalArticle

    Open Access
  • Effectiveness of first-line treatments in metastatic squamous non-small-cell lung cancer

    Levy, B. P., Signorovitch, J. E., Yang, H., Patterson-Lomba, O., Xiang, C. Q. & Parisi, M., Jan 1 2019, In : Current Oncology. 26, 3, p. e300-e308

    Research output: Contribution to journalArticle

    Open Access
  • Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer

    Levy, B., Giaccone, G., Besse, B., Felip, E., Garassino, M. C., Domine Gomez, M., Garrido, P., Piperdi, B., Ponce-Aix, S., Menezes, D., MacBeth, K. J., Risueño, A., Slepetis, R., Wu, X., Fandi, A. & Paz-Ares, L., Feb 1 2019, In : European Journal of Cancer. 108, p. 120-128 9 p.

    Research output: Contribution to journalArticle